Patient and Physician Satisfaction with Analgesic Treatment: Findings from the Analgesic Treatment for Cancer Pain in Southeast Asia (ACE) Study

Table 1

Demographics and characteristics of the analysis population ().

Age (years)
Mean (SD)	55.14 (13.39)
Age group, n (%)
18–29 years	17 (3.7)
30–39 years	54 (11.7)
40–49 years	74 (16.0)
50–59 years	139 (30.1)
60–69 years	113 (24.5)
70–79 years	53 (11.5)
80+ years	12 (2.6)
Gender, n (%)
Male	214 (46.3)
Female	248 (53.7)
Cancer stage, n (%)
0	4 (0.9)
I	11 (2.4)
II	32 (6.9)
III	79 (17.1)
IV	311 (67.3)
Not available	25 (5.4)
Metastasis, n (%)
Yes	303 (65.6)
No	144 (31.2)
Unknown	15 (3.2)
Received surgery/radiotherapy/chemotherapy, n (%)
Yes	430 (93.1)
No	32 (6.9)
Site of pain, n (%)^†
Head	48 (10.4)
Neck	50 (10.8)
Chest	103 (22.3)
Abdomen	90 (19.5)
Upper back	46 (10.0)
Lower back	107 (23.2)
Joints	56 (12.1)
Others	125 (27.1)
Worst pain intensity over the past 24 hours
Mean (SD)	4.76 (2.47)
Median (min, max)	5.00 (0.00, 10.00)
Sleep disturbance, n (%)
Yes	253 (54.8)
No	209 (45.2)
Quality of life assessed by EQ-5D-3L
Mobility, n (%)
No problems	193 (41.8)
Problems	269 (58.2)
Self-care, n (%)
No problems	281 (60.8)
Problems	181 (39.2)
Usual activities, n (%)
No problems	158 (34.2)
Problems	304 (65.8)
Pain/discomfort, n (%)
No problems	82 (17.7)
Problems	380 (82.3)
Anxiety/depression, n (%)
No problems	202 (43.7)
Problems	260 (56.3)

SD: standard deviation; ^†patients may experience more than one site of pain, percentages may not add up to 100%.